Insulin-like growth factor I in the kidney

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Insulin-like growth factor I (IGF-I) is produced in the kidneys and liver, with high serum levels primarily from hepatic synthesis.
• Circulating IGF-I is extensively bound by binding proteins, limiting its bioavailability.
• IGF-I exerts local effects within the kidney via autocrine, paracrine, and endocrine mechanisms.

Purpose of the Study:

• To elucidate the multifaceted roles of IGF-I in renal physiology and pathology.
• To investigate IGF-I's influence on glomerular filtration rate (GFR) and renal hemodynamics.
• To examine IGF-I's involvement in tubular phosphate transport and cellular processes within the nephron.

Main Methods:

• Review of existing literature on IGF-I synthesis, circulation, and renal actions.
• Analysis of IGF-I's effects on arteriolar resistance and glomerular permeability (LpA).
• In vitro and in vivo studies assessing IGF-I's impact on phosphate transport and renal hypertrophy.

Main Results:

• IGF-I enhances GFR by reducing arteriolar resistance and increasing LpA.
• IGF-I promotes phosphate reabsorption in renal tubules.
• IGF-I is implicated in initiating compensatory renal growth and extracellular matrix accumulation in chronic kidney diseases.
• In nephrotic syndrome, filtered IGF-I activates proximal tubule cell receptors.

Conclusions:

• IGF-I is a critical regulator of renal function, influencing hemodynamics, tubular transport, and cellular growth.
• Dysregulation of IGF-I signaling contributes to the pathogenesis of kidney diseases, including nephrotic syndrome.
• Targeting IGF-I pathways may offer therapeutic potential for renal disorders.